Chaoju Eye Care Holdings Limited filed its Monthly Return for Equity Issuer for the period ended 30 April 2026. Key takeaways are as follows:

• Authorised share capital remained unchanged at 1.52 billion ordinary shares with an aggregate par value of HKD 380,000.

• Issued share count held steady at 705.18 million ordinary shares. No new shares were issued, cancelled, or converted during the month, and the company reported zero treasury shares on hand.

• The company confirmed compliance with the Main Board’s minimum public-float requirement of 25 percent for the class of shares.

• Outstanding repurchase: 262,000 shares previously bought back on 6 June 2025 remain pending cancellation; no additional repurchases occurred in April 2026.

No movements were recorded under share options, warrants, convertibles, or other equity-linked instruments. The filing was signed by Executive Director and Joint Company Secretary Zhang Guangdi on 6 May 2026.